Can I Take Lion's Mane with Cialis (Tadalafil)?

What Is Tadalafil and How Does It Work?

Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor approved by the FDA for erectile dysfunction (ED), benign prostatic hyperplasia (BPH), and pulmonary arterial hypertension (PAH) [1]. It blocks PDE5, the enzyme that degrades cyclic guanosine monophosphate (cGMP) in smooth muscle cells. Elevated cGMP relaxes vascular and cavernosal smooth muscle, widening blood vessels and enabling penile erection in response to sexual stimulation.

Pharmacokinetics at a Glance

Tadalafil reaches peak plasma concentration in roughly 2 hours and carries a plasma half-life of approximately 17.5 hours, far longer than sildenafil's 4-hour half-life [1]. That extended window is why once-daily 2.5 mg or 5 mg dosing works for BPH and on-demand ED. The drug is metabolized almost exclusively by hepatic CYP3A4. Strong CYP3A4 inhibitors (ketoconazole, ritonavir) can raise tadalafil exposure by up to 124%, according to the prescribing information [1].

Blood Pressure Considerations

Because PDE5 inhibitors expand blood vessels, tadalafil produces a modest mean drop in systolic blood pressure of approximately 8 mmHg at the 10 mg dose in healthy volunteers [1]. That effect compounds with nitrates (an absolute contraindication), alpha-blockers, and antihypertensive agents. Any supplement that independently lowers blood pressure or inhibits platelet function becomes clinically relevant in this context.

What Is Lion's Mane and Why Do People Take It?

Lion's mane (Hericium erinaceus) is a white, shaggy edible fungus native to North America, Europe, and Asia. Supplement users take it primarily for reported cognitive benefits, peripheral nerve support, and mild mood stabilization. Two classes of bioactive compounds drive most of the research interest: hericenones (found in the fruiting body) and erinacines (found in the mycelium).

Nerve Growth Factor Stimulation

The most-studied action of lion's mane is induction of nerve growth factor (NGF) synthesis. A 2009 randomized, double-blind, placebo-controlled trial (N=30 Japanese adults aged 50-80) published in Phytotherapy Research found that 1,000 mg Hericium erinaceus three times daily for 16 weeks produced significantly higher Revised Hasegawa Dementia Scale scores compared with placebo, with no serious adverse events reported [2]. NGF stimulation is the proposed mechanism. This activity does not directly intersect with the PDE5 pathway.

Antiplatelet and Vascular Effects

This is where overlap with tadalafil becomes clinically meaningful. A 2010 in-vitro study demonstrated that hericenone B isolated from Hericium erinaceus inhibited ADP-induced platelet aggregation in human platelet-rich plasma [3]. A 2015 rodent study further reported that orally administered Hericium erinaceus extract reduced collagen-induced platelet aggregation and shortened bleeding time recovery in thrombocytopenic mice [4].

Neither study used human clinical doses commonly sold in supplements (500-3,000 mg/day), and no human RCT has specifically measured platelet function changes from lion's mane supplementation. The antiplatelet signal is real in the lab but unquantified in humans.

Nitric Oxide Pathway Overlap

Tadalafil depends on endogenous nitric oxide (NO) release from penile endothelium to initiate the cGMP cascade. Some Hericium erinaceus polysaccharide fractions have shown endothelial NO synthase (eNOS) upregulation in cell culture [5]. If this effect translates to humans at supplement doses, it could produce a modest additive vasodilation alongside tadalafil. That additive effect is unlikely to be dangerous in otherwise healthy men but could matter in men with borderline hypotension or those already on antihypertensives.

Is There a Direct Drug-Supplement Interaction?

No published human pharmacokinetic study has directly tested lion's mane alongside tadalafil. That absence of data cuts both ways. It does not confirm safety, but it also does not confirm harm. Based on what is known, the interaction profile breaks into two distinct categories.

Pharmacokinetic Interaction: Low Probability

Tadalafil is cleared by CYP3A4 [1]. A meaningful pharmacokinetic interaction would require lion's mane to inhibit or induce CYP3A4 substantially. Current evidence does not support that. A 2012 screen of common medicinal mushrooms found no significant CYP3A4 inhibitory activity from Hericium erinaceus fruiting-body extracts at concentrations relevant to oral supplement doses [6]. Lion's mane polysaccharides are large, polar molecules with limited hepatic penetration, making CYP interference at typical doses improbable.

No dose-separation window is required on pharmacokinetic grounds alone.

Pharmacodynamic Interaction: Moderate Attention Warranted

The antiplatelet data from hericenone B [3] and the possible eNOS upregulation [5] represent pharmacodynamic overlap with tadalafil's vasodilatory profile. Neither effect is expected to produce acute harm in healthy adults, but three specific populations face more pronounced risk.

First, men who take tadalafil alongside prescription anticoagulants (warfarin, apixaban, rivaroxaban) should be especially cautious about adding any supplement with antiplatelet activity. Second, men using alpha-blockers such as tamsulosin for BPH already face an elevated hypotension risk with tadalafil; additional vasodilation from lion's mane, even if minor, adds to that load. Third, men with a history of priapism or sickle cell disease should not combine vasodilatory agents without specialist guidance.

What Do Established Drug Interaction Databases Say?

Natural Medicines (the peer-reviewed supplement-drug interaction database used by many hospital pharmacies) rates the evidence for a lion's mane-tadalafil interaction as "insufficient" as of its most recent update, meaning no confirmed interaction has been documented but theoretical concerns exist based on pharmacology [7]. The Drugs.com interaction checker similarly returns no listed interaction between Hericium erinaceus and tadalafil, while flagging that supplement databases are incomplete by nature [8].

A rating of "insufficient evidence" does not mean the combination is free of risk. It means the human data needed to quantify that risk have not been collected.

HealthRX Interaction Risk Framework for Lion's Mane + Tadalafil

| Risk Dimension | Evidence Level | Clinical Weight | |---|---|---| | CYP3A4 pharmacokinetic interaction | Preclinical screen (negative) | Low | | Antiplatelet pharmacodynamic overlap | In-vitro, 1 rodent study | Moderate in anticoagulated patients | | Additive vasodilation (eNOS/NO pathway) | Cell culture only | Low-to-moderate in hypotension-prone patients | | Direct NGF-PDE5 interaction | No evidence | Negligible | | Human RCT safety data for combination | None published | Evidence gap |

Dosing Considerations If You Take Both

If your physician approves continuing both substances, the following considerations come from first principles pharmacology rather than direct combination trials.

Tadalafil Dosing Schedules

On-demand tadalafil for ED is typically prescribed at 10 mg or 20 mg taken 30 minutes to 12 hours before anticipated sexual activity. Daily tadalafil for ED or BPH uses 2.5 mg or 5 mg each morning [1]. The 17.5-hour half-life means that even "on-demand" use results in meaningful plasma levels for 36 hours or longer at standard doses.

Lion's Mane Dosing in Published Trials

The 2009 Mori et al. Trial used 3,000 mg/day of dried fruiting-body powder [2]. A 2020 pilot RCT (N=41) testing lion's mane for mild depression used 1,800 mg/day for 8 weeks and reported no cardiovascular adverse events [9]. Commercial supplements range from 500 mg to 3,000 mg per capsule serving. Higher doses theoretically carry greater antiplatelet activity given the dose-dependent nature of hericenone B inhibition observed in vitro [3].

Timing and Monitoring

Because no pharmacokinetic reason exists to separate doses in time, forced dose-separation offers no documented benefit here. The more practical step is to inform your prescriber that you are taking both, track your blood pressure at home if you are on antihypertensives, and report any unusual bleeding, prolonged erections lasting more than 4 hours, or sustained dizziness to your provider immediately.

Special Populations and Contraindications

Men on Anticoagulants

Any man taking warfarin, apixaban, rivaroxaban, dabigatran, or aspirin alongside tadalafil should treat lion's mane's antiplatelet signal as clinically meaningful until human data prove otherwise. The combined inhibition of multiple hemostatic pathways can increase bleeding risk in a roughly additive fashion, as established with other antiplatelet supplements such as fish oil and ginkgo [10].

Men with Cardiovascular Disease

The FDA-approved tadalafil prescribing information recommends caution in patients with resting hypotension (systolic blood pressure <90 mmHg), recent myocardial infarction within 90 days, or unstable angina [1]. Adding a vasodilatory supplement to an already borderline hemodynamic picture deserves explicit physician sign-off.

Women and Non-ED Uses

Some women use tadalafil off-label for pulmonary hypertension or Raynaud's phenomenon. Lion's mane is commonly taken by women for cognitive purposes. The same antiplatelet caution applies. Women who are pregnant or breastfeeding should avoid lion's mane entirely because no adequate safety data exist for those populations [7].

CYP3A4 Drug Interactions Already Present

If you are already on a CYP3A4 inhibitor (fluconazole, clarithromycin, grapefruit juice in large quantities) that has raised your tadalafil blood levels above the normal range, the threshold for any additional pharmacodynamic pressure on blood pressure or platelet function is lower. Disclose all concurrent medications and supplements to your telehealth or in-person provider.

What the Research Still Cannot Tell Us

This combination has not been tested in a single published human RCT. That gap matters. Preclinical antiplatelet effects of hericenone B were shown in isolated human platelets and rodent models, but translating those concentrations to real-world oral doses requires human bioavailability data that have not been published [3, 4]. The eNOS upregulation seen in cell culture used polysaccharide fractions at concentrations that may exceed what gut absorption delivers to the endothelium [5].

The Phytotherapy Research RCT by Mori et al. Is frequently cited as proof of lion's mane safety, but its primary endpoint was cognitive function in a dementia-screening population, not cardiovascular or hemostatic safety [2]. That trial did not enroll men on PDE5 inhibitors and was not powered to detect rare adverse events.

Researchers at the University of Malaya published a 2015 review noting that "despite the widespread traditional and commercial use of Hericium erinaceus, controlled clinical trials examining its safety profile in patients with concurrent cardiovascular drug use remain absent from the literature" [11]. That observation remains accurate in 2025.

Practical Guidance: What to Do Right Now

If you are already taking both lion's mane and tadalafil and have not experienced any adverse effects, you do not need to stop immediately. Follow these steps instead.

Tell your prescriber at your next visit, or send a message through your patient portal today if you are on anticoagulants or antihypertensives. Disclosing supplement use is the single most reliable way to get personalized guidance.

Monitor your blood pressure. Men on daily tadalafil 5 mg can experience average systolic reductions of 4-6 mmHg; if lion's mane produces even a 2-3 mmHg additive effect through eNOS upregulation, men with borderline blood pressure may notice symptoms. A home blood pressure cuff costs less than $30 and provides real data.

Check your supplement label for additional ingredients. Many lion's mane products are blended with other mushrooms (reishi, chaga, cordyceps) or adaptogenic herbs (ashwagandha, rhodiola). Reishi (Ganoderma lucidum) carries its own documented antiplatelet and antihypertensive activity [12], compounding the theoretical risk.

Stop lion's mane at least 7-10 days before any elective surgical procedure where bleeding is a concern. This mirrors existing guidance for fish oil and ginkgo, which carry similarly sized preclinical antiplatelet signals [10].

Frequently Asked Questions